Ipca Laboratories Ltd. · Q3FY26
Result on 13 Feb 2026, first traded on 16 Feb 2026; judged on 15 Sep 2026. The last read before it, on 7 Feb 2026 (6 days ahead), called it favourable, rank 91 of 367 reporting; the share then beat the market over ten sessions. The company's page →
read rightverdict
favourablethe read
+4.2%vs market, 10 sessions
+0.4%T+1
1 · What the read said
morning of 7 Feb- Read
- favourable — rank 91 of 367 reporting that week
- Composite
- 63.3 out of 100
- Evidence
- full · 14 results on record
- Expected move
- ±4.1% on the day — its average absolute move on results
- Habit
- mixed — the day-one move usually goes either way over the following sessions
- Close that morning
- ₹1,416.70
Reactivity · 30%
40
Momentum · 20%
80
vs market · 30%
58
vs sector · 20%
89
Each layer is a percentile among that week's reporters (0–100). A missing layer's weight is spread over the others.
Composite = 0.30 × 40.4 + 0.20 × 80.3 + 0.30 × 57.7 + 0.20 × 89.3 = 63.3
2 · What the result was
from the filing's XBRLNo reported figures on file for this quarter, so the result itself could not be graded — only the share's reaction was.
3 · What the share did
thirty sessions in, the result day, ten out · from the close before the resultsession closed upsession closed downNIFTY 50 (market)run-up into the result
Close before₹1,485.40the base every move below is measured from
T+1+0.4%less than 60% of its usual result-day move
T+10+1.9%market -2.4% · sector +3.4%
vs market+4.2%vs sector -1.6%
Best close after+2.9%traded as high as +4.2% on 26 Feb
Worst close after-2.4%traded as low as -3.3% on 20 Feb
Run-up, 30 sessions+6.2%into the result
52-week range6% below high17% above low
- Delivery share
- -5.8 points in the fortnight before, against the month before that
- Volume
- 1.03× its prior month, in the fortnight before
- Habit held
- mixed — could not be checked
- Announced
- Mon, timing unknown
- Peers reporting
- 8 sector peers reported the same week
4 · Why it went this way
- No reported figures on file for this quarter, so the result itself could not be judged.
- 8 sector peers reported the same week; the sector read may already have been set.
A strong or favourable read is right when the share beat the market by more than 2% over ten sessions; weak or unfavourable when it lagged by more. Inside ±2% is flat. Neutral reads make no call.
5 · Every morning's read before it
1 mornings| Morning | Days ahead | Read | Rank | Comp. | L1 | L2 | L3 | L4 | Close | Note |
|---|---|---|---|---|---|---|---|---|---|---|
| 7 Feb judged simulated | 6 | favourable | 91/367 | 63.3 | 40 | 80 | 58 | 89 | ₹1,416.70 |
A read is made each morning the company is due within seven days. The highlighted morning is the last one before the result — the read this post-mortem judges. Excluded mornings show why the name dropped out that day.
6 · Every session in the window
the last stop · each close, and where it stood against the close before the result| Session | Date | Open | High | Low | Close | Day | From base | NIFTY 50 from base | NIFTY PHARMA from base |
|---|---|---|---|---|---|---|---|---|---|
| T-28 | 2 Jan | 1,403.90 | 1,415.00 | 1,393.10 | 1,404.00 | — | -5.48% | +3.37% | +2.69% |
| T-27 | 5 Jan | 1,407.00 | 1,418.00 | 1,394.00 | 1,413.00 | +0.64% | -4.87% | +3.06% | +2.47% |
| T-26 | 6 Jan | 1,419.50 | 1,475.00 | 1,406.40 | 1,469.60 | +4.01% | -1.06% | +2.78% | +4.20% |
| T-25 | 7 Jan | 1,475.50 | 1,521.50 | 1,446.10 | 1,514.20 | +3.03% | +1.94% | +2.63% | +4.92% |
| T-24 | 8 Jan | 1,523.50 | 1,550.00 | 1,501.00 | 1,544.00 | +1.97% | +3.95% | +1.59% | +3.46% |
| T-23 | 9 Jan | 1,545.00 | 1,582.60 | 1,521.30 | 1,575.00 | +2.01% | +6.03% | +0.83% | +2.55% |
| T-22 | 12 Jan | 1,574.00 | 1,574.00 | 1,503.00 | 1,527.80 | -3.00% | +2.85% | +1.25% | +2.13% |
| T-21 | 13 Jan | 1,529.80 | 1,565.00 | 1,501.00 | 1,507.80 | -1.31% | +1.51% | +1.03% | +1.66% |
| T-20 | 14 Jan | 1,500.00 | 1,525.60 | 1,490.40 | 1,517.00 | +0.61% | +2.13% | +0.76% | +1.40% |
| T-19 | 16 Jan | 1,512.00 | 1,517.60 | 1,481.70 | 1,509.90 | -0.47% | +1.65% | +0.88% | +0.10% |
| T-18 | 19 Jan | 1,509.90 | 1,517.00 | 1,483.40 | 1,487.20 | -1.50% | +0.12% | +0.45% | -0.26% |
| T-17 | 20 Jan | 1,475.00 | 1,501.00 | 1,468.00 | 1,479.70 | -0.50% | -0.38% | -0.94% | -2.17% |
| T-16 | 21 Jan | 1,479.70 | 1,487.60 | 1,432.00 | 1,480.90 | +0.08% | -0.30% | -1.23% | -2.75% |
| T-15 | 22 Jan | 1,491.00 | 1,501.00 | 1,471.90 | 1,485.60 | +0.32% | +0.01% | -0.71% | -1.20% |
| T-14 | 23 Jan | 1,493.00 | 1,497.50 | 1,456.00 | 1,462.80 | -1.53% | -1.52% | -1.66% | -2.13% |
| T-13 | 27 Jan | 1,467.90 | 1,483.20 | 1,432.70 | 1,454.90 | -0.54% | -2.05% | -1.16% | -1.83% |
| T-12 | 28 Jan | 1,457.30 | 1,475.90 | 1,441.00 | 1,447.10 | -0.54% | -2.58% | -0.50% | -2.05% |
| T-11 | 29 Jan | 1,448.10 | 1,509.80 | 1,434.20 | 1,479.70 | +2.25% | -0.38% | -0.20% | -2.84% |
| T-10 | 30 Jan | 1,479.70 | 1,501.00 | 1,444.00 | 1,470.80 | -0.60% | -0.98% | -0.59% | -2.16% |
| T-9 | 2 Feb | 1,409.00 | 1,464.50 | 1,391.80 | 1,439.90 | -2.10% | -3.06% | -1.50% | -2.91% |
| T-8 | 3 Feb | 1,470.00 | 1,470.00 | 1,423.80 | 1,435.30 | -0.32% | -3.37% | +1.01% | +0.02% |
| T-7 | 4 Feb | 1,435.30 | 1,451.00 | 1,398.60 | 1,406.40 | -2.01% | -5.32% | +1.20% | -0.31% |
| T-6 | 5 Feb | 1,411.00 | 1,453.00 | 1,392.30 | 1,442.20 | +2.55% | -2.91% | +0.67% | -0.34% |
| T-5 | 6 Feb | 1,435.30 | 1,435.30 | 1,403.80 | 1,416.70 | -1.77% | -4.63% | +0.87% | -1.05% |
| T-4 | 9 Feb | 1,417.70 | 1,455.00 | 1,416.00 | 1,452.00 | +2.49% | -2.25% | +1.56% | +0.43% |
| T-3 | 10 Feb | 1,464.00 | 1,467.00 | 1,421.10 | 1,426.20 | -1.78% | -3.99% | +1.82% | +0.07% |
| T-2 | 11 Feb | 1,424.10 | 1,475.80 | 1,403.00 | 1,432.70 | +0.46% | -3.55% | +1.90% | +1.08% |
| T-1 | 12 Feb | 1,432.70 | 1,488.20 | 1,412.00 | 1,472.90 | +2.81% | -0.84% | +1.32% | +0.86% |
| base | 13 Feb | 1,458.00 | 1,503.90 | 1,428.80 | 1,485.40 | +0.85% | +0.00% | +0.00% | +0.00% |
| T+1 | 16 Feb result | 1,475.00 | 1,530.00 | 1,451.00 | 1,495.10 | +0.65% | +0.65% | +0.83% | +0.94% |
| T+2 | 17 Feb | 1,510.00 | 1,510.00 | 1,471.50 | 1,491.60 | -0.23% | +0.42% | +1.00% | +1.35% |
| T+3 | 18 Feb | 1,491.00 | 1,501.80 | 1,476.10 | 1,490.60 | -0.07% | +0.35% | +1.37% | +1.56% |
| T+4 | 19 Feb | 1,496.40 | 1,501.40 | 1,451.00 | 1,463.90 | -1.79% | -1.45% | -0.07% | +1.06% |
| T+5 | 20 Feb | 1,460.00 | 1,465.00 | 1,436.20 | 1,449.80 | -0.96% | -2.40% | +0.39% | +1.16% |
| T+6 | 23 Feb | 1,465.00 | 1,501.00 | 1,465.00 | 1,473.70 | +1.65% | -0.79% | +0.95% | +1.73% |
| T+7 | 24 Feb | 1,471.80 | 1,544.00 | 1,458.00 | 1,515.30 | +2.82% | +2.01% | -0.18% | +1.97% |
| T+8 | 25 Feb | 1,531.90 | 1,533.10 | 1,500.30 | 1,524.50 | +0.61% | +2.63% | +0.04% | +3.86% |
| T+9 | 26 Feb | 1,534.90 | 1,547.40 | 1,503.00 | 1,522.80 | -0.11% | +2.52% | +0.10% | +4.99% |
| T+10 | 27 Feb | 1,522.00 | 1,540.00 | 1,503.90 | 1,528.90 | +0.40% | +2.93% | -1.15% | +3.41% |
| T+11 | 2 Mar | 1,471.80 | 1,525.00 | 1,471.80 | 1,513.00 | -1.04% | +1.86% | -2.38% | +3.43% |
Prices are end-of-day from the exchange, adjusted for corporate actions. "From base" is the move from the close before the result — the same base every number on this page uses. Sessions before the base are the run-up.